Diario Médico has echoed that Fran Supek, head of the IRB Barcelona Genome Data Science group, has been awarded a Starting Grant from the European Research Council (ERC). This funding will be used to further his project. Supek aims to acquire greater knowledge of cancer biology in order to support the design of individualised therapies. To this end, he will analyse hypermutated tumours.
Link to Diario Médico
IRB Barcelona has been awarded two ERC PoC grants to optimise and validate tools with potential clinical applications.
Angel R. Nebreda’s project seeks to develop treatments to reduce the cardiotoxicity caused by chemotherapy.
Eduard Batlle’s project will build a biobank of mouse tumour organoids with the aim to contribute to the treatment of patients with advanced colon cancer.
Researchers at the Centre for Genomic Regulation (CRG) in collaboration with IRB Barcelona, developed a new method to systematically identify genes contributing to heritable cancer risk.
The study, published in Nature Communications, is a success story for data sharing and openness in science.
The newspaper El País has published an article about the implications of applying the CRISPR-Cas9 technique in human cells that could facilitate the appearance of tumours, according to two articles published in the journal Nature Medicine.
